| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85291245567731df2d5b9982ca81630f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-37 |
| filingDate |
2014-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9766521a8cb443aec5a3d94c328f1ca8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a22f6c81e8602bd6f3f2e0cfac8ae5d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5adbca30e89aa05c2396032c9dc8720e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b19185e5ddfb0089933e76698e4c6a05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9db128694133d4a2e4fc5294730bc8e4 |
| publicationDate |
2021-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2880835-T3 |
| titleOfInvention |
Pharmaceutical composition for cancer treatment and biomarker for drug screening |
| abstract |
Pharmaceutical composition for use in the treatment of cancer, comprising Sorafenib or a pharmaceutically acceptable salt thereof and 3-(3,5-dibromo-4-hydroxy-benzylidene)-5-iodo-1,3-dihydro-indol- 2-one or a pharmaceutically acceptable salt thereof. |
| priorityDate |
2014-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |